Growth Metrics

Verastem (VSTM) EBIAT (2018 - 2025)

Verastem has reported EBIAT over the past 8 years, most recently at -$32.9 million for Q4 2025.

  • Quarterly results put EBIAT at -$32.9 million for Q4 2025, up 49.01% from a year ago — trailing twelve months through Dec 2025 was -$209.5 million (down 60.35% YoY), and the annual figure for FY2025 was -$209.5 million, down 60.35%.
  • EBIAT for Q4 2025 was -$32.9 million at Verastem, up from -$98.5 million in the prior quarter.
  • Over the last five years, EBIAT for VSTM hit a ceiling of -$8.3 million in Q2 2024 and a floor of -$98.5 million in Q3 2025.
  • Median EBIAT over the past 5 years was -$22.4 million (2021), compared with a mean of -$28.6 million.
  • Biggest five-year swings in EBIAT: surged 66.0% in 2024 and later crashed 311.06% in 2025.
  • Verastem's EBIAT stood at -$16.5 million in 2021, then dropped by 1.98% to -$16.8 million in 2022, then plummeted by 62.83% to -$27.4 million in 2023, then tumbled by 135.86% to -$64.6 million in 2024, then surged by 49.01% to -$32.9 million in 2025.
  • The last three reported values for EBIAT were -$32.9 million (Q4 2025), -$98.5 million (Q3 2025), and -$25.9 million (Q2 2025) per Business Quant data.